The NDP-backed pharmacare plan is a corporate handout as written

The real problem with this signature legislation of the NDP-Liberal agreement is that it will not bring medicines within Canada’s publicly funded health system.
New Democratic Party leader Jagmeet Singh speaks with reporters in the House of Commons foyer before Question Period on June 3, 2024, about the upcoming vote on the government’s pharmacare bill.
It’s hard to square NDP Leader Jagmeet Singh’s concern over bowing to corporate interests with his party's support for such a pharmacare plan, write Steve Morgan, Matthew Herder, and Nav Persaud.

Jagmeet Singh has severed ties with the Liberals, citing Prime Minister Justin Trudeau’s capitulation to corporate interests as rationale. This declaration of people over profits is at odds with the NDP’s support for the

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.


Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past week’s opinion writers and columnists on Saturdays and Sundays.


By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy

MORE Opinion

RELATED STORIES